Merit Medical acquires vascular access system for $18.5 million

Michael Walter | | Cardiovascular Business | Economics

Merit Medical Systems announced this week that it has purchased the HeRO Graft vascular access system and its related assets from CryoLife for $18.5 million.

HeRO Graft has already received 510(k) clearance from the FDA and has the CE marking.

“This is a product line we have had interest in for some time,” Fred P. Lampropoulos, Merit chairman and CEO, said in a prepared statement. “We believe the HeRO Graft will help enhance our existing presence with vascular surgeons as well as interventional radiologists.  We believe other Merit product lines, such as our peritoneal dialysis catheters, which are most often implanted by vascular surgeons, and our line of chronic dialysis catheters, will be improved as well.  We understand that ninety percent of the HeRO Graft sales have been in the United States with the balance mainly in Germany and the United Kingdom.  We believe that a substantial opportunity exists in the international marketplace, especially with our global sales, marketing and clinical footprint.”

According to Merit’s calculations, the HeRO Graft’s revenues were approximately $7.5 million in 2015 and its gross margins were approximately 55 percent.

Merit Medical is a medical device company based out of South Jordan, Utah. CryoLife has its headquarters in Atlanta and manufactures, processes, and sells living tissues and medical devices.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Heartflow, a leader in AI-powered imaging evaluations, files for IPO
CMS proposal includes cardiologist pay bump—cuts to high-value services still a concern
AI-enabled coronary plaque evaluations included in new RBM guidelines
Medicare now covers TriClip procedures for patients with symptomatic tricuspid regurgitation
Medical malpractice lawsuits are rare in sports cardiology—but they can cost providers millions
PFA market heats up as medtech companies announce new investments

Around the web

Health Exec
Major association of physicians presents itself as a go-to alternative vs. the government on vaccine expertise

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations. 

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.